Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)

Historical Holders from Q2 2022 to Q2 2025

Symbol
CLRB on Nasdaq
Type / Class
Equity / Common stock, par value $0.00001
Shares outstanding
43,754,363
All holders as of 30 Jun 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-32
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LYTTON LAURENCE W 8.8% $1,147,086 3,955,470 LYTTON LAURENCE W 31 Dec 2024
Nantahala Capital Management, LLC 5.73% -42.6% $727,066 -$339,478 2,507,125 -31.8% Nantahala Capital Management, LLC 31 Dec 2024
HIRSCHMAN ORIN 4.9% $586,444 2,022,221 Orin Hirschman 31 Dec 2024

Institutional Holders of Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$1,628,323 0
2025 Q1 5,206,074 $1,628,323 +$18,097 $0.3153 32
2024 Q4 5,096,844 $1,524,202 -$20,663,936 $0.299 30
2024 Q3 14,004,954 $29,970,913 +$5,030,700 $2.14 34
2024 Q2 11,593,733 $28,257,451 +$5,519,090 $2.5 37
2024 Q1 9,130,425 $36,338,536 +$2,839,872 $3.98 45
2023 Q4 8,583,076 $23,775,177 +$10,367,185 $2.77 25
2023 Q3 1,458,347 $3,849,839 -$264,709 $2.64 20
2023 Q2 1,578,100 $3,077,507 -$217,766 $1.95 19
2023 Q1 1,692,997 $2,432,105 -$324,073 $1.43 18
2022 Q4 1,881,137 $3,216,474 +$2,148,426 $1.71 23
2022 Q3 636,480 $2,139,000 +$2,116,000 $3.36 18
2022 Q2 56,000 $23,000 +$23,000 $0.4107 1